1 Glenmark's Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the ...

Acetylcysteine 100mg/mL, 200mg/mL; soln for inhalation; preservative-free. See literature for administration of aerosol. Nebulization-face mask, mouth piece, tracheostomy: 1–10mL of 20% soln or ...

Glenmark Pharmaceuticals Inc., USA announced today the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials in the US market. The shares of Glenmark ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Acetylcysteine Injection will be launched in 6 gm/30 mL (200 mg/mL) single-dose vials, and will be made available to hospitals and other system-wide healthcare providers. Acetylcysteine is a ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch of acetylcysteine injection, 6 gm/30 mL (200 mg/mL) single-dose vials. Glenmark’s acetylcysteine injection, 6 gm/30 ...

MAHWAH, N.J., March 3, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the Acquisition and launch 1 of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials.